FindTrial
Sign In

A clinical trial to study the effects of dexmeditomedine in paediatric patients undergoing general anaesthesia

STUDY OF DOSE RELATED EFFECTS OF DEXMEDETOMIDINE ON LARYNGEAL MASK AIRWAY REMOVAL IN CHILDREN UNDER GOING HERNIOTOMY -A DOUBLE BLIND RANDOMIZED STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012117
Enrollment
90
Registered
2018-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- paediatric patients undergoing hernia,circumission

Interventions

Intervention1: dexmedetomidine: The patients will be randomly allocated into either of the three groups saline (Group S), dexmedetomidine 0.5µg/kg (Group D0.5) or dexmedetomidine 1 µg/kg (Group D1)

Sponsors

SDM COLLEGE OF MEDICAL SCIENCES HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Pediatric patients in age group 1 to 12 years 2)ASA physical status I or II )Patients undergoing herniotomy or circumcision under general anaesthesia

Exclusion criteria

Exclusion criteria: 1)ASA physical status III or IV 2)Patients having arrhythmias 3)Congenital heart disease 4)Respiratory tract infection 5)Difficult airway 6)Allergic to the medications being used • No consent for the procedure

Design outcomes

Primary

MeasureTime frame
Smooth removal of Laryngeal Mask Airway in children undergoing herniotomy. Timepoint: End of the surgery and anaesthesia—

Secondary

MeasureTime frame
1) Intraoperative hemodynamic stability. 2) Emergence time. 3) Respiratory complications. 4) Recovery time Timepoint: Intraoperative period and postoperative recovery period.—

Countries

India

Contacts

Public ContactDr Sandeep Shetty

SDM College Of Medical Sciences & Hospital

kakkodravi@yahoo.co.in9482181582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026